{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:41:57Z","timestamp":1790919717087,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035133","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:03:43Z","timestamp":1334783023000},"page":"e35133","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified \u03b3-Secretase Complexes"],"prefix":"10.1371","volume":"7","author":[{"given":"Matthias","family":"Cacquevel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lor\u00e8ne","family":"Aeschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemila","family":"Houacine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Fraering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer&apos;s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer&apos;s disease type 3 gene.","volume":"376","author":"EI Rogaev","year":"1995","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer&apos;s disease.","volume":"375","author":"R Sherrington","year":"1995","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0962-8924(02)00041-7","article-title":"Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides.","volume":"13","author":"A Weihofen","year":"2003","journal-title":"Trends Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/35017062","article-title":"Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.","volume":"2","author":"WP Esler","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.","volume":"398","author":"MS Wolfe","year":"1999","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1074\/jbc.275.5.3173","article-title":"The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation.","volume":"275","author":"WT Kimberly","year":"2000","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00018-008-7462-2","article-title":"Substrate specificity of gamma-secretase and other intramembrane proteases.","volume":"65","author":"AJ Beel","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref8","article-title":"Processing of the synaptic cell-adhesion molecule neurexin-3{beta} by Alzheimer&apos;s disease {alpha}- and {gamma}-secretases.","author":"N Bot","year":"2010","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tig.2007.01.008","article-title":"Presenilin diversifies its portfolio.","volume":"23","author":"AL Parks","year":"2007","journal-title":"Trends Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","article-title":"Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.","volume":"25","author":"Y Qi-Takahara","year":"2005","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1.","volume":"56","author":"Q Liu","year":"2007","journal-title":"Neuron"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nature04667","article-title":"TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.","volume":"440","author":"F Chen","year":"2006","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature09325","article-title":"Gamma-secretase activating protein is a therapeutic target for Alzheimer&apos;s disease.","volume":"467","author":"G He","year":"2010","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1152\/physiol.00009.2008","article-title":"Presenilins: members of the gamma-secretase quartets, but part-time soloists too.","volume":"23","author":"T Wakabayashi","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer&apos;s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.","volume":"3","author":"M Citron","year":"1997","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.59.3.398","article-title":"Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer&apos;s disease.","volume":"59","author":"A Delacourte","year":"2002","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.410430217","article-title":"Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.","volume":"43","author":"ND Mehta","year":"1998","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(99)00187-1","article-title":"Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer&apos;s disease.","volume":"265","author":"O Murayama","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1523\/JNEUROSCI.20-23-08717.2000","article-title":"Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.","volume":"20","author":"R Siman","year":"2000","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.112686799","article-title":"Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.","volume":"99","author":"T Moehlmann","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/bi0267590","article-title":"Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells.","volume":"42","author":"Y Qi","year":"2003","journal-title":"Biochemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JAD-2004-6105","article-title":"A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations.","volume":"6","author":"WK Dowjat","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","article-title":"Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.","volume":"96","author":"M Bentahir","year":"2006","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1171176","article-title":"gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer&apos;s disease.","volume":"324","author":"L Serneels","year":"2009","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"24277","DOI":"10.1074\/jbc.M211992200","article-title":"Partial purification and characterization of gamma-secretase from post-mortem human brain.","volume":"278","author":"MR Farmery","year":"2003","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1021\/bi0494976","article-title":"Purification and characterization of the human gamma-secretase complex.","volume":"43","author":"PC Fraering","year":"2004","journal-title":"Biochemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2007.05041.x","article-title":"Rapid purification of active gamma-secretase, an intramembrane protease implicated in Alzheimer&apos;s disease.","volume":"104","author":"M Cacquevel","year":"2008","journal-title":"J Neurochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1073\/pnas.0602321103","article-title":"Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores.","volume":"103","author":"VK Lazarov","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jmb.2008.10.078","article-title":"Cryoelectron microscopy structure of purified gamma-secretase at 12 A resolution.","volume":"385","author":"P Osenkowski","year":"2009","journal-title":"J Mol Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.96.21.11872","article-title":"Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.","volume":"96","author":"A Herreman","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1242\/jcs.00292","article-title":"gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation.","volume":"116","author":"A Herreman","year":"2003","journal-title":"J Cell Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"43430","DOI":"10.1074\/jbc.M306957200","article-title":"Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin.","volume":"278","author":"O Nyabi","year":"2003","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80291-3","article-title":"Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.","volume":"17","author":"G Thinakaran","year":"1996","journal-title":"Neuron"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI30447","article-title":"Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.","volume":"117","author":"O Nelson","year":"2007","journal-title":"J Clin Invest"},{"key":"ref35","article-title":"A presenilin-1 mutation identified in familial Alzheimer&apos;s disease with cotton wool plaques causes nearly complete loss of {gamma}-secretase activity.","author":"EA Heilig","year":"2010","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0014-5793(99)00730-9","article-title":"A novel substrate for analyzing Alzheimer&apos;s disease gamma-secretase.","volume":"453","author":"SF Lichtenthaler","year":"1999","journal-title":"FEBS letters"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/bi035748j","article-title":"Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex.","volume":"43","author":"PC Fraering","year":"2004","journal-title":"Biochemistry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.","volume":"383","author":"K Duff","year":"1996","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).","volume":"13","author":"T Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0021-9258(18)48529-8","article-title":"Assembly and aggregation properties of synthetic Alzheimer&apos;s A4\/beta amyloid peptide analogs.","volume":"267","author":"D Burdick","year":"1992","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.1074\/jbc.M803159200","article-title":"The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.","volume":"283","author":"A Jan","year":"2008","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer&apos;s disease.","volume":"32","author":"JT Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer&apos;s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer&apos;s disease.","volume":"2","author":"D Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.","volume":"4","author":"L Holcomb","year":"1998","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0197-4580(01)00280-9","article-title":"Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice.","volume":"23","author":"DR Borchelt","year":"2002","journal-title":"Neurobiol Aging"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.","volume":"7","author":"R Radde","year":"2006","journal-title":"EMBO Rep"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer&apos;s disease increases beta-protein production.","volume":"360","author":"M Citron","year":"1992","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The Swedish mutation causes early-onset Alzheimer&apos;s disease by beta-secretase cleavage within the secretory pathway.","volume":"1","author":"C Haass","year":"1995","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"21636","DOI":"10.1074\/jbc.M109.088005","article-title":"Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.","volume":"285","author":"LM Munter","year":"2010","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/nbdi.1998.0183","article-title":"Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.","volume":"5","author":"M Citron","year":"1998","journal-title":"Neurobiol Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/humu.9458","article-title":"Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques.","volume":"27","author":"C Dumanchin","year":"2006","journal-title":"Hum Mutat"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.","volume":"27","author":"S Kumar-Singh","year":"2006","journal-title":"Hum Mutat"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.274.12.7615","article-title":"The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing.","volume":"274","author":"H Steiner","year":"1999","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","article-title":"Variant Alzheimer&apos;s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations.","volume":"48","author":"H Houlden","year":"2000","journal-title":"Ann Neurol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuron.2005.04.008","article-title":"Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.","volume":"46","author":"R Pardossi-Piquard","year":"2005","journal-title":"Neuron"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1523\/JNEUROSCI.0527-10.2010","article-title":"Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signaling.","volume":"30","author":"K Veeraraghavalu","year":"2010","journal-title":"J Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","article-title":"Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration.","volume":"42","author":"CA Saura","year":"2004","journal-title":"Neuron"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1471-4159.2011.07501.x","article-title":"gamma-Secretase inhibitors and modulators for Alzheimer&apos;s disease.","volume":"120","author":"MS Wolfe","year":"2012","journal-title":"Journal of neurochemistry"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.22365","article-title":"What the halted phase III gamma-secretase inhibitor trial may (or may not) be telling us.","volume":"69","author":"NF Schor","year":"2011","journal-title":"Annals of neurology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2009-0957","article-title":"Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain.","volume":"16","author":"X Xu","year":"2009","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"ref61","first-page":"Unit 12 10","article-title":"Production and titration of lentiviral vectors.","volume":"Chapter 12","author":"P Salmon","year":"2007","journal-title":"Curr Protoc Hum Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:35:35Z","timestamp":1713872135000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035133"}},"subtitle":[],"editor":[{"given":"Stefano L.","family":"Sensi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035133","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}